Twenty minutes per day of walking or bicycling were associated with a lower rate of fracture.
A pooled analysis examined the rates of amputation and fracture in patients with type 2 diabetes prescribed empagliflozin.
A 2.5 times higher fracture risk was noted among elderly patients taking sleeping pills.
Long-term denosumab increased bone mineral density in postmenopausal women.
Women who had taken oral contraceptives for more than 5 years had the lowest risk for fracture.
Study examines the predictive value for vertebral fractures of bone mineral density and bone turnover markers after a 5-year drug holiday.
The risk of developing fracture in postmenopausal women with osteoporosis who discontinued bisphosphonate therapy was evaluated in a retrospective study.
Patients with psoriatic arthritis or psoriasis had an increased prevalence of osteoporosis risk factors.
Endocrinology Advisor Articles
- Major Cardiovascular Event Incidence in T2D: Degludec vs Glargine
- Semaglutide Improved Beta-Cell Function and Glycemic Control in Type 2 Diabetes
- Maternal Deaths in the United States: Sounding a Call to Action
- Blood Glucose Self-Monitoring in Type 2 Diabetes Does Not Benefit Glycemic Control
- The Handoff: Your Week in Endocrinology News - 6/23/17
- Reduced Cardiovascular Events in Type 2 Diabetes Treated With Dapagliflozin
- Canagliflozin Reduces Cardiovascular Stress In Older Patients With Type 2 Diabetes
- Diabetic Retinopathy Caused by Sleep Apnea in T2D
- Transition-of-Care Algorithm Performs Well in Surgery Patients With Type 2 Diabetes
- GLP-1 Analog Counteracts Antipsychotic-Induced Glucose Intolerance, Weight Gain